Monograph
J01DB03 - Cefalotin |
Propably not porphyrinogenic |
PNP |
Rationale
Cefalotin has no potentially porphyrinogenic pharmacokinetic or pharmacodynamic properties.
Chemical description
Beta-lactam antibiotic.
Therapeutic characteristics
Cefalotin is a semi synthetic first generation parental cephalosporin with a broad spectrum of antibiotic activity. It is used in the treatment of infections and for surgical infection prophylaxis.
Metabolism and pharmacokinetics
Cefalotin is partly metabolized to a less active desacetyl metabolite. 50-75% of the drug is eliminated unchanged in the urine. It has a half-life of 30-50 minutes. Not suspected to have any effect on the activities of cytochrome P450 enzymes.
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Drug reference publications | |
| 1. | DrugBank. Cefalotin.
|
|
| * | Drug interaction databases | |
| 2. | Lexicomp Online. Martindale: The Complete Drug Reference. Cefalotin Sodium. (27.07.2010)
|
|
| * | Summary of Product Characteristics | |
| 3. | Norwegian medicines agency. Summary of Product Characteristics (SPC). Keflin.
|
|
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Cefalotin
© NAPOS 2025